The effect of rs9939609 polymorphism of the FTO A23525T gene on obesity in patients with chronic hepatitis C
Patient-Oriented Medicine and Pharmacy · 27.04.2026 · 4 (1) · 53-60
DOI: 10.37489/2949-1924-0130 ↗Kurz gefasst
Fachartikel in der Zeitschrift Patient-Oriented Medicine and Pharmacy, online erschienen am 27.04.2026. Verfasst von A. A. Koklyushkina und 2 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
Relevance. Chronic hepatitis C (CHC) remains one of the global health problems, being the leading cause of cirrhosis, hepatocellular carcinoma, and the need for liver transplantation. The combination of CHC and obesity creates a synergistic negative effect, significantly worsening the response to treatment and the prognosis of the disease. In this regard, an in-depth study of the pathogenetic mechanisms underlying this relationship, particularly the role of genetic factors, is an extremely relevant area of modern hepatology.
Objective
To study the effect of the rs9939609 polymorphism of the FTO A23525T gene on obesity in patients with chronic hepatitis C. Materials and methods. The study was conducted at the Regional Infectious Diseases Clinical Hospital in Yaroslavl, where a sample of 240 patients aged 18–60 years was formed. As part of the study, all participants provided their medical histories and underwent anthropometric measurements (waist circumference and body mass index calculation). To verify chronic hepatitis C, we used ELISA to detect a spectrum of antibodies (a-cor, a-NS3, a-NS4, a-NS-5) in the blood serum, as well as PCR to detect hepatitis C virus RNA (HCV). The degree of hepatitis activity was assessed by the level of liver transaminases in the blood serum. Molecular genetic analysis, including the study of the rs9939609 polymorphism of the FTO gene (A23525T), was carried out in the clinical and diagnostic laboratory of the Institute of Pharmacy of the Federal State Budgetary Educational Institution of Higher Education «Yaroslavl State Medical University». Real-time PCR was used for genotyping on the «iCycler iQ5» (BioRad) amplifier with the «SNP-express-RV» reagent kit. The patients underwent liver elastometry using the FibroScan 502 device from Echosens, with interpretation of the METAVIR stage.
Results
According to the inclusion criteria, the patients were divided into groups: the first (main) group consisted of patients with CSC and obesity (124 patients), and the second (comparison) group consisted of patients with CSC without obesity (116 patients). Correlations were established between the FTO A23525T gene genotypes and obesity, as well as the possible impact on the severity of HCV infection and the stage of liver fibrosis.
Conclusion
In patients with HCV and obesity, there is a direct correlation between the body mass index and waist circumference. In patients with different FTO gene genotypes, there is a possible effect on the severity of hepatitis and the stage of liver fibrosis.
Zitieren
APA
Koklyushkina, A. A., Bokhonov, M. S., & Sitnikov, I. G. (2026). The effect of rs9939609 polymorphism of the FTO A23525T gene on obesity in patients with chronic hepatitis C. Patient-Oriented Medicine and Pharmacy, 4(1), 53-60. https://doi.org/10.37489/2949-1924-0130
Vancouver
Koklyushkina AA, Bokhonov MS, Sitnikov IG. The effect of rs9939609 polymorphism of the FTO A23525T gene on obesity in patients with chronic hepatitis C. Patient-Oriented Medicine and Pharmacy. 2026;4(1):53-60. doi:10.37489/2949-1924-0130
BibTeX
@article{Koklyushkina2026,
author = {Koklyushkina, A. A. and Bokhonov, M. S. and Sitnikov, I. G.},
title = {The effect of rs9939609 polymorphism of the FTO A23525T gene on obesity in patients with chronic hepatitis C},
journal = {Patient-Oriented Medicine and Pharmacy},
year = {2026},
volume = {4},
number = {1},
pages = {53--60},
doi = {10.37489/2949-1924-0130}
}
EUVIMED